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Branched poly(N-isopropylacrylamide) was functionalized
with Amphotericin B (AmB) at the chain ends to produce
an antifungal material. The polymer showed antifungal
properties against AmB-sensitive strains of Candida albicans,
Fusarium keratoplasticum and Aspergillus flavus (minimal
inhibitory concentration ranged from 5 to 500 µg ml−1) but was
not effective against an AmB resistant strain of C. albicans nor
against Candida tropicalis. The polymer end groups bound to
the AmB target, ergosterol, and the fluorescence spectrum of a
dye used as a solvatochromic probe, Nile red, was blue shifted
indicating that segments of the polymer became desolvated on
binding. The polymer was less toxic to corneal and renal
epithelial cells and explanted corneal tissue than the free drug.
Also, the polymer did not induce reactive oxygen species
release from peripheral blood mononuclear cells, nor did it
cause a substantial release of the proinflammatory cytokines,
tumour necrosis factor-α and interleukin-1β (at 0.5 mg ml−1).
1. Introduction
Although several antibacterial polymer systems have been
developed [1–4], there has so far been less interest in the
development of fungicidal polymers. However, fungal infections
© 2021 The Authors. Published by the Royal Society under the terms of the Creative
Commons Attribution License http://creativecommons.org/licenses/by/4.0/, which permits
unrestricted use, provided the original author and source are credited.
are of great importance owing to complications in other diseases [5]. For example, recent studies (inCanadian
intensive care units) showed up to 50% of critically ill patients were colonized with Candida sp. [6,7] and
mortality rates as high as 60% in nocosomial infections have been reported [6,8,9]. Fungal infections are
also of particular concern for immune-compromised patients [10,11] and in tropical climates, fungal
infections are common, resulting in significant problems in eye infections [12,13]. However, the current
pipeline for the development of antifungal agents with novel mechanisms is lacking [14].
Amphotericin B (AmB), is used as an antifungal drug but it is toxic to human tissue [15,16] particularly
causing nepthrotoxicity [17,18]. The mode of action of AmB involves binding to ergosterol by providing
face-to-face contacts between the macrolide and the ergosterol tetracyclic core, resulting in the creation of
transmembrane channels, leading to the leakage of intracellular components and subsequent cell death [19].
Conventionally AmB is delivered as the deoxycholate complex (Fungizone) but this is highly toxic,
limiting its usage to life-threatening fungal infections [20]. Lipid formulations provide lower toxicity
while retaining similar efficacy to the deoxycholate complex [21]. However, significant numbers
(10–25%) of patients still develop nephrotoxicity [22]. Recent attempts to formulate optimal dosage
have included attaching the drug to nanoparticles [23,24], delivery within polymer micelles [25,26],
conjugation to poly(ethylene glycol) chain ends [27,28], and modifying with sugar moieties [16,29–32].
In this study, we show that AmB attached to a highly branched polymer had antifungal activity but
its toxicity to human cells in vitro was significantly reduced.
Previously, we have shown that highly branched poly(N-isopropylacrylamide)s (HB-PNIPAM)s with
either vancomycin [33,34] or polymyxin [35] at the chain ends desolvate on binding Gram-positive or
Gram-negative bacteria, respectively. In this first example of combining a branched polymer with fungi-
binding end groups, we attached AmB to HB-PNIPAM. Currently, only a few polymeric conjugates
with AmB are known. For example a poly(styrene-co-maleic anhydride)-AmB material was active
against Saccharomyces cerevisiae but with three times lower efficacy than fungizone or AmB [36], while
pectin conjugates showed lower activity against Candida albicans [32]. We show also, in vitro, that the
polymer exhibits much-decreased toxicity to epithelial cells. To facilitate pre-clinical biological
evaluation these studies, peripheral blood mononuclear cells (PBMCs), comprised of T and B cells,
natural killer cells and monocytes, are widely used as clinically relevant models of the human cellular
response. There are no studies reporting the response of PBMCs or purified immune cells to poly(N-
isopropyl acrylamide) (PNIPAM) or copolymers. However, changes in cytokine production have been
reported in vivo when copolymer composition was changed in poly(NIPAM-co-acrylic acid) statistical
copolymer microgels [37]. Also, Fan et al. [38] showed that murine macrophage-like RAW264.7
produced low amounts of the cytokine interleukin-1β (IL-1β) after 48 h on PNIPAM copolymer surfaces.
Proinflammatory cytokines, such as IL-1β and tumour necrosis factor-α (TNF-α), are critical mediators
of the inflammatory response, and as such these cytokines are key indicators of the inflammatory response.
2. Results
2.1. Synthesis and characterization of highly branched poly(N-isopropylacrylamide)-
Amphotericin B
The structure of AmB is shown in figure 1a, with linkage to the polymer via amidation of carboxylic acid
functional HB-PNIPAM. HB-PNIPAM with a high concentration of carboxylic acid end groups was
synthesized by the method reported previously [39], using self-condensing vinyl reversible addition-
fragmentation transfer polymerization in the presence of a vinyl functional benzyl dithioate ester (4-
vinylbenzyl-pyrrolecarbodithioate, VPC), which acted as a branching agent. The polymerization
produced polymer with pyrrole end groups (HB-PNIPAM-Py). The ratio of NIPAM : VPC in the
monomer feed was 25 : 1 and the final conversion of monomer was 96%. The chain ends were then
modified to carboxylic acid and amidated with AmB via activation of the end groups as the
succinimidyl ester. The reaction was carried out at pH 11 to fully solubilize the AmB.
The HB-PNIPAM-AmBwas purified by repeated precipitation into diethyl ether, and then ultrafiltration
in water through a 10 kDa membrane filter to retain only high molar mass material. The feed, molar mass
averages and functionality are set out in the table in figure 1. The size exclusion chromatography data,
shown in figure 1b, are derived from the refractive index (RI) and ultraviolet visible (UV/Vis) detectors.
The UV/vis data were collected at 405 nm, λmax for AmB and showed that the polymer contained no AmB
that was not covalently attached to the chain end. This result was confirmed using electrospray mass









S1–S4),which is far below theminimum inhibitory concentration (MIC= 4.68–150 µmol dm−3 [26]) for AmB.
HB-PNIPAM-AmB produced by this procedure and after purification was a high molar mass material with
broad dispersity (figure 1c). The presence ofAmB on polymer chainswas demonstrated by 1H (NMR spectra
are provided in the electronic supplementary material) and the functionalization with AmB was
demonstrated by the peaks at between 4 and 6.5 ppm from the newly incorporated polyene ring (electronic
supplementary material, figure S5). Diffusion-ordered spectroscopy (DOSY) NMR (electronic
supplementary material, figures S6 and S7) was also used to reveal the polymer hydrodynamic radii (RH)
distribution in dimethyl sulphoxide (DMSO) [40]. The number and weight average hydrodynamic radii
were RH,n = 2.55 nm and RH,w = 2.60 nm. The table shows the reactant feeds in the functionalization
reaction, molar masses and functionalities.
2.2. Highly branched poly(N-isopropylacrylamide)-Amphotericin B responds to binding
ergosterol
The polymers were responsive to temperature and showed a coil-to-globule (Tc−g) desolvation. Tc−g of
these polymers determined by calorimetry (electronic supplementary material, figure S8) was 36.2°C
HB-PNIPAM-AmB RI ×5 mV,
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Figure 1. Synthesis of HB-PNIPAM-AmB. (a) Schematic diagram showing a generalized structure of HB-PNIPAMwith chain end functionality
(blue) and a chain end segment with an amphotericin end group. SEC data: (b) RI and UV data for HB-PNIPAM-AmB and AmB. (c) Molar mass
distributions of as prepared polymer (HB-PNIPAM-Py) and HB-PNIPAM-AmB. Asterisk denotes molar masses were obtained by size exclusion
chromatography in methanol. Hash indicates functionality (F) expressed as molar percentage of chain ends carrying an AmB moiety
determined from 1H nuclear magnetic resonance (NMR). Circled times symbol represents amount of AmB per unit mass of polymer









in aqueousmedia. The functionalizationwithAmB led to an increase inTc−g; fromapeakof 18.9°C for the as
prepared pyrrole-functional material. The desolvation at Tc−g can be monitored using the addition of
solvatochromic fluorescent dyes such as Nile red [39]. The emission wavelength of the Nile red dye
reflects the average internal polarity of the chain segments between the swollen and desolvated forms.
Decreasing the peak wavelength of the emission spectra indicated increasing hydrophobicity
(desolvation) of the environment. A solution of HB-PNIPAM-AmB was mixed with Nile red and studied
both in the presence and absence of ergosterol across a temperature range 5–45°C (figure 2 and electronic
supplementary material, figure S9). The data (figure 2a) showed a blue shift in the peak emission
wavelength of Nile red with temperature (p < 0.001) in both the presence and absence of ergosterol when
the dye was mixed with HB-PNIPAM-AmB (p < 0.001). However, at all temperatures, the spectra shifted
to lower wavelength on the addition of ergosterol. Figure 2b shows that the fluorescence intensity also
increased as the temperature increased and that at all temperatures the peak intensity was higher in the
presence of ergosterol ( p < 0.001). Figure 2 also shows data from similar experiments carried out with the
HB-PNIPAM-Py. Figure 2a shows that there was no significant shift in peak emission wavelength on
adding ergosterol. Also, figure 2b shows that although there were increases in fluorescence intensity,
owing to non-specific binding, the magnitude of the change was much less than when ergosterol was
bound to HB-PNIPAM-AmB. Thus, the data indicated that ergosterol was bound to the AmB ligands at
the chain ends of HB-PNIPAM-AmB and this binding induced a desolvation that reduced the average
polarity of the environment into which Nile red was portioned.
Figure 2a shows that there is a blue shift of approximately 20 nm in the spectra as both HB-PNIPAM-
AmB and HB-PNIPAM-Py pass the through Tc−g. Binding of ergosterol produces a small but consistent
(across all temperatures) blue shift in HB-PNIPAM-AmB. Figure 2b shows that for HB-PNIPAM-AmB the
blue shift is accompanied with a significant ( p < 0.001) increase in peak fluorescence intensity.
2.3. Highly branched poly(N-isopropylacrylamide)-Amphotericin B is active against fungi
Next, AmB and HB-PNIPAM-AmB were incubated with AmB sensitive and non-sensitive species of
fungi to determine the MIC (table 1). HB-PNIPAM-Py, without the AmB functionality, was ineffective
against fungi (MIC > 2500 µg ml−1). The MIC of free AmB was similar for two different AmB-sensitive
strains of C. albicans and there was little difference between two strains in the efficacy of the polymer
against them. However, although HB-PNIPAM-AmB was effective against these strains it was less so
than free AmB.
Ergosterol synthesis is impaired in both C. albicans ATCC200955 and Candida tropicalis ATCC200956
and these strains were resistant to both AmB and HB-PNIPAM-AmB up to 2500 µg ml−1. Fusarium























































Figure 2. (a) Peak wavelength and (b) emission intensity of Nile red mixed with HB-PNIPAM-AmB alone (open circle) or with
equivalent molar amounts of ergosterol ( filled circle) or with HB-PNIPAM-Py alone (open red circle) or with equivalent molar
amounts of ergosterol ( filled red circle). Polymer concentrations = 1 mg ml−1 in aqueous solution. Asterisks indicate
significance: asterisks, between comparisons of HB-PNIPAM-AmB; asterisks, between comparisons of HB-PNIPAM-Py; p < 0.05,









HB-PNIPAM-AmB was also effective against this species with a similar increase in the MIC to the C.
albicans strains that were sensitive to AmB.
Aspergillus flavus 16 883 is commonly associatedwith agricultural diseases but in tropical climates, it is an
opportunistic pathogen that is amajor cause ofmicrobial keratitis. The data in table 1 showed thatA. flavus 16
883 was less sensitive to AmB than the C. albicans strains and free AmB was more effective against this
organism than HB-PNIPAM-AmB. However, the polymer with a molar MIC that was raised by
approximately ×102 compared to AmB, HB-PNIPAM-AmB did have some efficacy against this species.
Therefore, these data indicate that HB-PNIPAM-AmB could be an effective therapeutic agent against
some pathogenic fungi. The polymer was effective against organisms that were known to be sensitive to
AmB but the MIC was substantially increased against an organism that was known to be less susceptible.
Similarly, neither AmB nor HB-PNIPAM-AmB were effective against micro-organisms in which synthesis
of the target (ergosterol) was impaired. It seems reasonable, therefore, to put forward the hypothesis that
the action of the polymer-bound drug and the free drug operate with the same mechanism. Additionally,
it is well known that AmB has low solubility in aqueous media at physiological pH. Conversely, up to
300 mgml−1 of HB-PNIPAM-AmB could be dissolved before viscous gelation started to occur.
2.4. Highly branched poly(N-isopropylacrylamide)-Amphotericin B has lower toxicity to
epithelial cells and tissue than Amphotericin B
As a key potential use of HB-PNIPAM-AmB could be as a treatment of eye infections, cytotoxicity was
examined using rabbit corneal epithelial cells and human explanted corneas. The toxicity of the polymer
against human renal epithelial cells (HREPs) was also determined, given the well-reported nephrotoxicity
of AmB. Figure 3a,b shows a dose-dependent decrease in cell viability as the concentration of AmB was
increased. There was a significant reduction (p < 0.01) in the cell viability of cells after exposure to
10 µg ml−1 AmB compared with the cell only control (4.8 ± 0.1% and 100 ± 5.2%, respectively), suggesting
that a concentration of 10 µg ml−1 would damage approximately 95% of the cells in the area in which it
was applied. By contrast there was no significant loss in cell viability when exposed to the HB-PNIPAM-
AmB even at 5 mg ml−1, which is far in excess of the weight-based MIC data reported in table 1. Figure 3c
shows the effects that increasing concentrations of AmB and similar concentrations of HB-PNIPAM-AmB
had upon the human corneal cells located in the human corneas. The corneas subjected to HB-PNIPAM-
AmB had minimal cell death, with survival rates of greater than 85% after 48 h exposure to concentrations
of 15 mg ml−1 whereas the cornea exposed to AmB showed only 10% (p < 0.01) survival when treated
with a concentration of 2.5 mg ml−1 or greater. AmB is also known to have an effect on the human renal
systemby twomechansims: decreased glomerular filtration rate [17] and damage to renal epithelial cells [41].
2.5. Response of peripheral blood mononuclear cells
We, therefore, also examined the effect of the polymer on primary HREPs. Figure 3d,e shows the cell
viability of HREPs exposed to AmB and HB-PNIPAM-AmB. When exposed to 100 µg ml−1 AmB the
Table 1. MIC values for AmB, HB-PNIPAM-Py and HB-PNIPAM-AmB for two AmB sensitive (SC5314, ATCC90028) and two
resistant (ATCC200956, ATCC 200955) Candida spp., Aspergillus flavus ATCC16883 and Fusarium keratoplasticum ATCC36031.
weight-based MICa (µg ml−1) molar MICb (µmol µl−1)
AmB HB-PNIPAM HB-PNIPAM-AmB AmB HB-PNIPAM-AmB
C. albicans SC5314 0.4 >2500 4.9 0.43 1.23
C. albicans ATCC90028 0.5 >2500 4.0 0.54 1.00
C. albicans ATCC200955 >2500 >2500 >2500 — —
C. tropicalis ATCC200956 >2500 >2500 >2500 — —
F. keratoplasticum ATCC 36031 0.2 >2500 6.25 0.216 1.56
A. flavus ATCC 16883 1.5 >2500 500 1.62 125.00
aThe weight based MIC is the total mass per unit volume including the polymer and the amphotercin end groups.









cell viability fell to 20% compared to the control (p < 0.001). On the other hand, there was no significant
difference between the cells exposed to 20 mg ml−1 of HB-PNIPAM-AmB and untreated controls. The
results suggest that when AmB is attached to the polymer there is significantly less cytotoxicity
compared with AmB alone. In order to evaluate the biological impact of this polymer on the immune
response in vitro, we assessed key indicators including metabolic activity, oxidative stress and
inflammatory cytokine release from four individual human donors of PBMCs.
PBMCs do not proliferate in culture without stimulation and the MTT assay can be used to monitor
metabolic activity as a result of activation [42]. Figure 4 shows how the relative metabolic activity (optical
density relative to cells without treatment) changed from samples derived from the four donors. The data










































































































Figure 3. Cell viability, relative to untreated controls: (a) AmB and (b) HB-PNIPAM-AmB with rabbit limbal epithelial cells.
(c) Human cells in explanted human cornea, (d ) AmB and (e) HB-PNIPAM-AmB with human renal epithelial cells (MTT). Data
obtained after exposure to HB-PNIPAM-AmB (filled square) or AmB (open circle) for 48 h. Error bars are standard error of the
mean (n = 3). All concentrations of HB-PNIPAM-AmB are the weight of total polymer per unit volume. The data show that
AmB is more toxic to epithelial cells and tissue than the polymer. Significance: (a,b,e,d) indicated between treated and









control (H2O2) for all samples. Relative metabolic activity from donors A and B remained at levels that
were similar or higher than the negative control (untreated PBMCs). Increased metabolic activity is an
indication of activation.
However, cells fromdonors C andD showed reduced activity, which probably is an indication of reduced
numbers of cells, at the highest concentration (50 mg ml−1) of HB-PNIPAM-AmB. Previously, we showed
that HB-PNIPAM can be endocytosed by fibroblasts [43] and it is known that endocytosis of biomaterials
can induce oxidative stress as mitochondrial disruption can lead to reactive oxygen species (ROS) release
into the cytoplasm [44]. Excess ROS produced by mitochondria are important in cell signalling [45] but
excess ROS result in oxidative stress. Monitoring ROS, therefore, is a useful indicator of cytotoxicity.
Figure 5 shows that there was no significant release of ROS, compared to the untreated controls, when
HB-PNIPAM-AmB was in contact with PBMCs for 24 h. PBMCs release TNF-α and IL-1β, within a few
hours, in response to stimulation by LPS [46,47] and AmB has also been shown to increase levels of these
proinflammatory cytokines [48]. Figures 6 and 7 show data for the release of TNF-α and IL-1β also
determined over 24 h in PMBCs from four donors. The positive control was lipopolysaccharide (LPS)
and untreated cells were used as negative controls.
Figure 6 shows that the PBMCs released TNF-α in varying amounts over the 24 h period. The data
showed that the cells exposed to LPS released large amounts of this cytokine, which remained
relatively high after 24 h. Untreated cells did not release TNF-α. Among the four donors, two different
types of behaviour were observed. Firstly, there was no significant difference between cells treated
with HB-PNIPAM-AmB from donors A and D and the non-treated cells. However, cells from donors
B and C released significant amounts of this cytokine. In each sample, the amount released peaked
over the 24 h time period and then diminished.
It was not possible in these data to discern a dose response effect and a similar observation was
reported recently by Batista-Durharte et al. [49] in their studies on a AmB-B/Cochleate system. In the
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Figure 4. Relative metabolic activity (MTT, optical density of sample/optical density of untreated control) of PBMCs in contact with
HB-PNIPAM-AmB. PBMCs derived from four anonymous donors. The data are relative to cell only controls and compared to H2O2
positive controls. Asterisks indicate significance. The black asterisks indicate that all of the HB-PNIPAM-AmB concentrations were
significantly different to the H2O2 control. The brown asterisks, red asterisks and blue asterisks indicate that individual
concentrations of HB-PNIPAM-AmB were significantly different to the H2O2.









cells from donors B and C the temporal response to HB-PNIPAM-AmB was greater than to LPS; at
various time points larger amounts of TNF-α were released after treatment with HB-PNIPAM-AmB
than with LPS.
However, in the cells from each donor, the HB-PNIPAM-AmB at the lowest concentration (0.5 mg ml−1)
induced release of TNF-α that was always significantly lower than the LPS controls after 12 h. Despite the
response in cells from two of the donors, after 24 h the amounts of TNF-α in the supernatants was lower
than the LPS controls (p < 0.05).
Figure 7 shows the pattern of IL-1β release from the PBMCs. The cells treated with LPS released
increasing amounts of this cytokine over time while the non-treated cells released negligible amounts.
The pattern of release of IL-1β was also variable between donors. However, a clear and consistent
pattern was observed such that there were no significant increases in the release of IL-1β when the
cells were treated with 0.5 mg ml−1 of HB-PNIPAM-AmB. On the other hand concentrations of
HB-PNIPAM-AmB above 0.5 mg ml−1 stimulated the release of IL-1β at levels similar to or higher
than that with the LPS positive control. Also, at these concentrations (above 0.5 mg ml−1) in the cells
derived from all donors, the release at the end of the experiment was higher ( p < 0.05) or equal to
cells treated with LPS. Thus, the data show minimal stimulation of the release of this cytokine up to a
concentration of 0.5 mg ml−1 but significant release above this concentration.
3. Discussion
Following our previous work on HB-PNIPAMs that showed beneficial responses against bacteria
[33–35,39,50,51], a similar polymer with end groups that bind to fungi was synthesized. This was
achieved by amidation of the polymer carboxylic acid end groups with the mycosamine group on
AmB. The polymer was a high molar mass material with approximately 75% of the available end
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Figure 5. Release of reactive oxygen species in contact with HB-PNIPAM-AmB. Asterisks indicate significance relative to positive









AmB is active against many fungi and we showed that the HB-PNIPAM-AmB was also active against
C. albicans strains that were sensitive to AmB (SC5314 and ATCC90028). Similarly, both AmB and HB-
PNIPAM-AmB had similar MICs against F. keratoplasticum ATCC 36031. The polymer was also
partially effective against A. flavus ATCC 16883 but with a higher MIC than against the other species.
Both AmB and HB-PNIPAM-AmB were shown to be not effective against C. albicans ATCC200955 and
C. tropicalis ATCC200956, which are strains known to be not sensitive to AmB. HB-PNIPAM-AmB,
therefore, was shown to have similar but lower activity to AmB.
AmB acts by binding to ergosterol to form channels in the fungal cell membrane. Ergosterol also
bound to the AmB end groups attached to HB-PNIPAM-AmB and polymer segments became
desolvated on binding. The channels form as a result of the amphiphilic nature of AmB. In
transmembrane channels, the hydrophobic polyene segments bind to ergosterol in the lipid
environment of the cell membrane and the polyol segments face an aqueous phase forming a
transmembrane pore, composed of single or double lengths of the AmB : ergosterol complex [52].
However, at lower concentrations ‘non-aqueous’ pores are formed, which do not cross the membrane
but in which AmB is inserted into the bi-layer [53]. Ergosterol sits within the cell membrane beneath
the cell wall. The cell wall of fungi is porous and in studies on yeast (S. cerevisiae) with linear
polymers of various sizes, it has been shown that macromolecules with RH of up to 5.8 nm can
permeate through [54] and much larger deformable vesicles have also been shown to deliver AmB to
the inner membrane [55]. The cell membrane is thus accessible to polymeric drugs. The data
presented here showed that HB-PNIPAM-AmB both bound to ergosterol and was effective against a











































































HB-PNIPAM-AmB 0.5 mg ml–1
HB-PNIPAM-AmB 5 mg ml–1 HB-PNIPAM-AmB 50 mg ml–1
untreated cellsLPS
Figure 6. Release of TNF-α following treatment with HB-PNIPAM-AmB concentrations of cytokines in supernatants (cells seeded at
20 000 cells per well) up to 24 h after treatment with HB-PNIPAM-AmB or LPS. Asterisks and plus signs indicate significance. The
black asterisks indicate that all of the HB-PNIPAM-AmB concentrations were significantly different to the LPS control at the stated
time point. The brown asterisks, red asterisks and blue asterisks indicate significant differences between individual concentrations of
HB-PNIPAM-AmB with LPS. p < 0.05, p < 0.01, p < 0.001. The black plus signs indicate that all of the HB-PNIPAM-AmB
were significantly different to the untreated cells at the stated time points. The brown plus, red plus and blue plus










molar mass but compact branched polymer would also diffuse through the cell wall to reach the
ergosterol targets.
The polymer reported in this current study here had similar but lower activity to free AmB but much
lower toxicity to two types of epithelial cells and cells in the explanted cornea. AmB was attached to the
HB-PNIPAM via the amine group, which is adjacent to the C20 hydroxyl group. The C20 hydroxyl group
is also involved in binding to cholesterol. Binding to cholesterol in human cells has been implicated in the
toxicity of AmB and Brandon et al. [56] showed that deleting the C20 hydroxyl group minimized this
interaction while binding to ergosterol was maintained. More work is required to fully determine the
mechanism but it seems reasonable that the close proximity of the polymer segments to C20 could
have similar effects to deletion, possibly owing to competitive hydrogen bonding between the C20
hydroxyl and the acrylamide units. One application under consideration for these materials is to treat
fungal keratitis. The ocular environment is immune privileged and the minimal toxicity to cornel
epithelial cells in explanted cornea provides significant progress to an effective therapeutic system for
fungal infections of the eye. However, in blood-contacting applications, for example in wounds
infected with fungi, it is important to consider the response of cells of the immune system. The in vivo
response to a material involves interaction with proteins and immune cells [57] and here we chose to
study the response of PBMCs over 24 h. The cells of the immune system undergo oxidative bursts of
ROS, which is part of the response to microbes. It was shown that HB-PNIPAM-AmB over 24 h did
not generate ROS in the PBMCs when compared to untreated cells and the data indicate minimal ROS
































































































Figure 7. Release of IL-1β following treatment with HB-PNIPAM-AmB concentrations of IL-1β in supernatants (cells seeded at
20 000 cells per well) up to 24 h after treatment with HB-PNIPAM-AmB or LPS. There is no significant increase in the release
of IL-1β following treatment with 0.5 mg ml−1 of HB-PNIPAM-AmB but concentrations of over 5 mg ml−1 stimulated release
of increased amounts of this cytokine. Asterisks and plus signs indicate significance. The black asterisks indicate that all of the
HB-PNIPAM-AmB concentrations were significantly different to the LPS control at the stated time point. The brown asterisks,
red asterisks and blue asterisks indicate significant differences between individual concentrations of HB-PNIPAM-AmB with LPS.
p < 0.05, p < 0.01, p < 0.001. The black plus signs indicate that all of the HB-PNIPAM-AmB were significantly different
to the untreated cells at the stated time points. The brown plus, red plus and blue plus signs indicate significant differences









range of cytokines. In this respect, TNF-α and IL-1β are important in the inflammatory response and they
are implicated in the adverse effects of AmB [58]. HB-PNIPAM-AmB did initiate a release of these
inflammatory cytokines but TNFα was reduced to levels similar to the untreated controls after 24 h
and the cells did not release IL-1β at a concentration of 0.5 mg ml−1. Thus, the data justify further
considerations aimed at using HB-PNIPAM-AmB as a low toxicity variant of AmB.
4. Experimental
4.1. Synthesis
4.1.1. Synthesis of highly branched poly(N-isopropylacrylamide)-Amphotericin B
HB-PNIPAM with COOH end groups (HB-PNIPAM-COOH) was prepared as previously described [39].
The detail of the synthesis is described in §2 of the supporting information. The HB-PNIPAM-COOH
(5.00 g) was dissolved in dimethyl formamide (DMF) (55 ml). To this, a solution of N-
Hydroxysuccinimide (0.858 g, 7.46 mmol) and N-N-Dicyclohexylcarbodimide (DCC) (1.539 g, 7.46 mmol)
in DMF (15 ml) was added. The mixture was stirred under N2 overnight and all solid products removed
via gravity filtration. The remaining solution was precipitated into diethyl ether, dissolved in ethanol and
concentrated via ultrafiltration three times. The remaining solvent was removed by rotary-evaporation
and the solid dried under vacuum at room temperature. This HB-PNIPAM with succinimide end groups
(1.00 g) was dissolved in ice-cold water (50 ml). A solution of AmB (30 mg, 0.032 moles) in 0.1 M sodium
phosphate buffer (pH 8.5, 10 ml) and water (10 ml) was added to the polymer solution (1.0 g). The
solution pH was increased to pH 11 (by addition of 0.01 M NaOH) while stirring on ice overnight, then at
room temperature for 24 h. The solution was ultrafiltered in water using 10 kDa pore membrane filters in
water at pH 11 (250 ml extracted—repeated seven times), then once again at pH 7 (250 ml extraction)
before the sample was freeze-dried. The final product was a pale yellow solid (0.99 g yield) and was
characterized by 1H NMR [400 MHz, DMSO (ppm): 1.05 (6H, s, -N(CH3)2) 1.55 (2H, br m, CH2-CH-Ar-)
2.01 (2H, br m, -CH2-CH-CO-NH-), 3.82 (H2O-polymer), 7.26 (br m, -Ar-)], sulfur content (0.24%), 4.5–6.5
(multiple peaks (see the electronic supplementary material, figure S1, (C=C–C)) and DOSY (RHn=
2.55 nm, RHw = 2.66 nm) and stored at −18°C.
4.2. Solubility of highly branched poly(N-isopropylacrylamide)-Amphotericin B
Solutions of up to 300 mg ml−1 of HB-PNIPAM-AmB were found to be stable for 24 h on a workbench. In
the same timeframe solutions of 400 mg ml−1 fully dissolved but became a viscous gel.
4.3. Fluorescence dye studies of polymer solutions
A stock solution of Nile red was prepared (0.4 mg cm−3, DMSO). This was diluted (to 10−7 mol dm−3) with
ultrapurewater. HB-PNIPAMpolymers (11 mg)were dissolved in ultrapurewater (7 ml) andNile red stock
solution (100 µl) was added. The fluorescence spectrum was then recorded on a Horiba Fluoromax-4
excitation 580 nm, emission 560–800 nm, with slit widths of 1 nm. Peak wavelength emission and
intensity was calculated from the Gaussian distribution of wavelengths. The data for peak wavelength
and emission intensity were compared using 2-way ANOVA using Fishers LSD post hoc analysis.
4.4. Fungi
Culture conditions for fungi. Candida albicans cells, laboratory strain SC5314 or ATCC90028, were cultured on
solid brain heart infusion (BHI) (Oxoid) medium at 37°C for 24 h and stored at 4°C for up to one month.
Prior to experiments, a colony of C. albicans was sub-cultured into liquid BHI medium overnight at 37°C.
Candida albicans (Robin) ATCC200955, C. tropicalis ATCC200956, A. flavus ATCC16883 and F.
keratoplasticum ATCC36031 were similarly cultured on solid Sabrauds (Oxoid) medium at 37°C for 24 h
and stored at 4°C for up to one month. Prior to experiments, colonies were sub-cultured into liquid
Sabrauds medium overnight at 37°C. All liquid cultures were static apart from A. flavus which was
incubated shaking at 100 rpm.
MICs for amphotericin polymers. Overnight cultures were adjusted to an optical density at 600 nm of 0.1









16 h at 37°C in a 96 well plate. The concentration of polymer at which there was no visible growth was
determined to be the MIC.
4.5. Cells and tissue
4.5.1. Isolation and culture of rabbit limbal epithelial cells
Limbal rims from corneal-scleral buttons were excised from wild brown rabbit heads, as previously
described [59]. Tissue was immersed in 2.5 mg ml−1 (w/v) dispase II solution in Dulbecco’s minimum
essential medium (DMEM) for 1 h at 37°C. The limbal rims were subsequently scraped gently using
forceps to remove the epithelial cells. The dispase-cell suspension was centrifuged at 200 g for 5 min
and resuspended in culture medium containing DMEM: Ham’s F12 (1 : 1) supplemented with 10%
fetal calf serum, 100 U ml−1 penicillin and 100 U ml−1 streptomycin, 2.5 µg ml−1 AmB, 5 µg ml−1
insulin and 10 ng ml−1 epidermal growth factor. Cells were cultured with irradiated 3T3-mouse
fibroblasts at a cell density of 2.4 × 104 cells cm−2 in culture medium. Cells were not used beyond
passage 3. For experiments, cells were seeded into 24 well plates at 5 × 104 cells per well and cultured
for 24 h.
4.5.2. Rabbit limbal epithelial cell viability
Prior to determining the viability of rabbit limbal epithelial cells, cells were washed 3× with phosphate-
buffered saline (PBS; 0.01 M, pH 7.4) to remove residual antimicrobials. HB-PNIPAM-AmB (20, 15,
10, 5, 4, 3, 2, 2.5, 1 and 0 mg ml−1) or AmB (0, 1, 10, 100 and 1000 µg ml−1 or 0, 2.5, 5, 10, 15 and
20 mg ml−1) were dissolved in culture medium without penicillin, streptomycin or AmB, and added to
pre-seeded epithelial cells for a further 24 h. Epithelial cell viability was determined using Alamar Blue
reagent (5 µg ml−1) dissolved in PBS. Cells were incubated with Alamar Blue for 30 min and the
fluorescence of the solution determined at 570 nm excitation and 585 nm emission (Infinite 200, Tecan).
Data for each polymer is presented as percentage viability relative to an untreated control. Each assay
was performed in triplicate and data represents the mean ± s.e.m. from three independent experiments.
The data were compared to the untreated cells using one-way ANOVA with Tukey post hoc. The
varianceswere calculated via the propagation of errors following the calculation of the percentage viability.
4.5.3. Human renal epithelial cell culture
Primary HREPs purchased from Promocell (Germany) were maintained in low-serum (5% V/V) renal
cell epithelial cell growth medium 2 supplemented with the associated SupplementPack. All cells
were maintained at 37°C in a 5% CO2 atmosphere with 95% humidity. The cell growth medium was
replaced every 2–3 days and cells were passaged once confluent.
4.5.4. Human renal epithelial cell viability
A MTT assay (Merck) was used to assess cell viability. HREPs were plated in flat bottomed poly-d-
lysine-coated 96-well plates at a density of 20 000 cells per well and incubated with AmB or
HB-PNIPAM-AmB at the indicated concentrations for 24 h. Ten microlitres of MTT reagent was
subsequently added to each well and the plate incubated at 37°C for 4 h. One-hundred microlitres of
solubilization solution was then added per well and the cells incubated at 37°C overnight before
reading the absorbance at 570 nm using a Tecan Infinite F50 plate reader running Magellan for F50
software. The data are presented as the percentage of the optical density of the cell only control. The
data were compared to the untreated cells using one-way ANOVA with Tukey post hoc. The variances
were calculated via the propagation of errors following the calculation of the percentage viability.
4.5.5. Human excised corneas
Cell viability tests were performed on the cadaveric human corneas which were unsuitable for transplant.
These were acquired from the Ramayamma International Eye Bank, LV Prasad Eye Institute, Hyderabad,
India. All corneas were obtained following procedures approved by the institutional review board for the
protection of human subjects. Isolation and culture of human corneas were performed as previously
described. [35]. Prior to use, corneas were washed three times with PBS and incubated in antibiotic-









range of concentrations (2.5, 5, 10, 15, 20 mg ml−1) were dissolved in the culture media and added to the
ex vivo cornea for 24 h at 37°C. The metabolic activity of the cells was measured by an Alamar Blue assay.
Briefly 100 µl Alamar Blue was added to each cornea and incubated at 37°C for 2–4 h. The fluorescence
was then read on plate reader (Spectra Max M3 using SoftMax Pro Data Acquisition and Analysis
Software) and expressed as percentage viability compared to control cells. The data were analysed
using two-way ANOVA with repeated measures and post hoc analysis with Sidak’s procedure for
comparison of two means. The data are presented as the percentage of the untreated controls. The
variances were calculated via the propagation of errors following the calculation of the percentage
viability.
4.5.6. Isolation and culture of primary blood mononuclear cells
Whole peripheral blood was taken from healthy human donors (approval 17/YH/0086) and the PBMCs
isolated using Sepmate50 tubes with Lymphoprep as the density gradient medium. PBMCs were
separated by centrifugation at (1200g) for 10 min, followed by the removal of the PBMC-containing
supernatant. Cells were washed with calcium-free PBS containing 2% fetal bovine serum (FBS) three
times by centrifugation at (800g) for 8 min. Cells were incubated for 24 hr in 5% (v/v) CO2 at 37°C in
RPMI 1640 culture medium (RCM) (RPMI 1640 (ThermoFisher Scientific) supplemented with GlutaMAX
supplement, supplemented with 10% FBS (ThermoFisher Scientific), 2 mM L-Glutamine (ThermoFisher
Scientific) and 100 U ml−1 penicillin-streptomycin (ThermoFisher Scientific)) before the addition of
polymer solutions or controls as indicated. PBMCs were incubated with the polymers for 3, 6, 12, 18 or
24 h as indicated.
4.5.7. Cell viability testing of primary blood mononuclear cells
Cell viability was evaluated using an MTT assay (Merck). PBMCs were plated at a density of 20 000 cells
per well in flat bottomed 96-well plates and incubated with polymers at three different concentrations for
3, 6, 12, 18 or 24 h as outlined above. Following this, 10 µl of MTT reagent was added to each well and
incubated at 37°C for 4 h. One-hundred microlitres of solubilization solution was then added to each well
and the cells incubated at 37°C overnight before recording the absorbance at 570 nm with a Tecan Infinite
F50 plate reader running Magellan for F50 software. The data were analysed using two-way ANOVA
with Tukey post hoc. The data are presented as the percentage of the untreated controls. The variances
were calculated via the propagation of errors following the calculation of the percentage viability.
4.5.8. Oxidative stress testing
Oxidative stress in PBMCs was determined by measuring ROS release using a DCFDA cellular ROS
detection assay kit (Abcam) according to the manufacturer’s instructions. Briefly, PBMCs were seeded
onto black, clear-bottomed 96-well plates and incubated with polymers for the specified period of
time. Eleven microlitres of the tertiary butyl peroxide positive control in phenol red-free RCM was
added to the relevant wells for a final concentration of 50 µM and the cells incubated at 37°C for 3 h
45 min. Cells were then treated with 25 µM DCFDA in phenol red-free RCM and incubated at 37°C
for 45 min and the fluorescence immediately measured using a Promega Explorer microplate reader
with the excitation and emission wavelengths of 475 nm and 500–550 nm, respectively. The data were
analysed using two-way ANOVA with Dunnett’s post hoc procedure for comparison to the non-treated
cells control.
4.5.9. Measurement of inflammatory cytokine release
Measurement of TNF-α and IL-1β in cell culture media was analysed by sandwich enzyme-linked
immunosorbent assay (ELISA) (Diaclone). Assays were carried out according to the manufacturer’s
instructions. The data were analysed using two-way ANOVA with Tukey post hoc procedure.
5. Conclusion
In conclusion, HB-PNIPAM with AmB end groups binds to ergosterol and provides a desolvation phase
transition of a fraction of polymer segments. The polymers are much less toxic than the free drug to









that were below the MICs for C. albicans and F. keratoplasticum. The polymers are active against fungi and
demonstrate therapeutically useful MICs as well as providing an increase in fluorescence intensity on
binding to the membrane target, ergosterol.
Ethics. Ethical approval was obtained from University of Bradford ethics committee and the L. V. Prasad ethics
committee.
Data accessibility. Provided as the electronic supplementary material.
Authors’ contributions. S.R.: supervision of T.S. and E.C., wrote the paper and analysed the data. T.S.: synthesis of
polymers, characterization and photo physics. E.C.: monocyte work and HREP culture. A.P.: microbiology work.
N.S.: microbiology and cornea work. P.G.: supervision of N.S., clinical input, micro and cornea work. C.W.I.D.:
microbiology supervision. S.M.: supervision of cell culture.
Competing interests. There are no conflicting financial interests of the authors.
Funding. The work was funded by the Welcome Trust DBTAlliance (0998800/B/12/Z) and MRC (UK) (grant no. 16038).
Acknowledgements. The authors thank Mr David Pownall for technical support of the synthesis work.
References
1. Yuan SJ, Xu FJ, Pehkonen SO, Ting YP, Neoh KG,
Kang ET. 2009 Grafting of antibacterial polymers
on stainless steel via surface-initiated atom
transfer radical polymerization for inhibiting
biocorrosion by Desulfovibrio desulfuricans.
Biotechnol. Bioeng. 103, 268–281. (doi:10.
1002/bit.22252)
2. Mizutani M, Palermo EF, Thoma LM, Satoh K,
Kamigaito M, Kuroda K. 2012 Design and
synthesis of self-degradable antibacterial
polymers by simultaneous chain- and step-
growth radical copolymerization.
Biomacromolecules 13, 1554–1563. (doi:10.
1021/bm300254s)
3. Liu R et al. 2014 Tuning the biological activity
profile of antibacterial polymers via subunit
substitution pattern. J. Am. Chem. Soc. 136,
4410–4418. (doi:10.1021/ja500367u)
4. Kenawy E-R, Worley SD, Broughton R. 2007
The chemistry and applications of antimicrobial
polymers: a state-of-the-art review.
Biomacromolecules 8, 1359–1384. (doi:10.1021/
bm061150q)
5. Casadevall A. 2017 Don’t forget the fungi when
considering global catastrophic biorisks. Health
Secur. 15, 341–342. (doi:10.1089/hs.2017.0048)
6. Al-Dorzi HM, Sakkijha H, Khan R, Aldabbagh T,
Toledo A, Ntinika P, Al Johani SM, Arabi YM.
2020 Invasive candidiasis in critically Ill
patients: a prospective cohort study in two
tertiary care centers. J. Intensive Care Med. 35,
542–553. (doi:10.1177/0885066618767835)
7. Laverdiere M, Labbé A-C, Restieri C, Rotstein C,
Heyland D, Madger S, Stewart T. 2007
Susceptibility patterns of Candida species
recovered from Canadian intensive care units.
J. Crit. Care 22, 245–250. (doi:10.1016/j.jcrc.
2006.10.038)
8. Bassetti M, Righi E. 2015 Overview of fungal
infections - the Italian experience. Semin. Respir.
Crit. Care Med. 36, 796–806. (doi:10.1055/s-
0035-1562890)
9. Gudlaugsson O, Gillespie S, Lee K, Berg JV,
Hu J, Messer S, Herwaldt L, Pfaller M,
Diekema D. 2003 Attributable mortality
of nosocomial candidemia, revisited.
Clin. Infect. Dis. 37, 1172–1177. (doi:10.
1086/378745)
10. Denning DW. 2016 Minimizing fungal disease
deaths will allow the UNAIDS target of
reducing annual AIDS deaths below 500 000
by 2020 to be realized. Phil. Trans. R.
Soc. B 371, 20150468. (doi:10.1098/rstb.
2015.0468)
11. Thomas PA. 2003 Fungal infections of the
cornea. Eye 17, 852–862. (doi:10.1038/sj.eye.
6700557)
12. Gow NAR, Netea MG. 2016 Medical mycology
and fungal immunology: new research
perspectives addressing a major world health
challenge. Phil. Trans. R. Soc. B 371, 20150462.
(doi:10.1098/rstb.2015.0462)
13. Sengupta J, Khetan A, Saha S, Banerjee D,
Gangopadhyay N, Pal D. 2012 Candida Keratitis.
Cornea 31, 371–375. (doi:10.1097/ICO.
0b013e31823f8a71)
14. Campoy S, Adrio JL. 2017 Antifungals. Biochem.
Pharmacol. 133, 86–96. (doi:10.1016/j.bcp.
2016.11.019)
15. Brockbank KGM, Dawson PE. 1993 Cytotoxicity
of amphotericin B for fibroblasts in human
heart valve leaflets. Cryobiology 30, 19–24.
(doi:10.1006/cryo.1993.1003)
16. Kagan S et al. 2012 Toxicity mechanisms of
amphotericin B and its neutralization by
conjugation with arabinogalactan. Antimicrob.
Agents Chemother. 56, 5603–5611. (doi:10.
1128/AAC.00612-12)
17. Sabra R, Branch RA. 1990 Amphotericin B
nephrotoxicity. Drug Saf. 5, 94–108. (doi:10.
2165/00002018-199005020-00003)
18. Laniado-Laborín R, Cabrales-Vargas MN. 2009
Amphotericin B: side effects and toxicity. Rev.
Iberoam. Micol. 26, 223–227. (doi:10.1016/j.
riam.2009.06.003)
19. Nakagawa Y, Umegawa Y, Matsushita N,
Yamamoto T, Tsuchikawa H, Hanashima S,
Oishi T, Matsumori N, Murata M. 2016
The structure of the bimolecular complex
between amphotericin B and ergosterol in
membranes is stabilized by face-to-face van der
Waals interaction with their rigid cyclic cores.
Biochemistry 55, 3392–3402. (doi:10.1021/acs.
biochem.6b00193)
20. Hartsel S, Bolard J. 1996 Amphotericin B:
new life for an old drug. Trends Pharmacol.
Sci. 17, 445–449. (doi:10.1016/S0165-
6147(96)01012-7)
21. Larabi M, Pages N, Pons F, Appel M, Gulik A,
Schlatter J, Bouvet S, Barratt G. 2003 Study of
the toxicity of a new lipid complex formulation
of amphotericin B. J. Antimicrob. Chemother. 53,
81–88. (doi:10.1093/jac/dkh025)
22. Wade RL, Chaudhari P, Natoli JL, Taylor RJ,
Nathanson BH, Horn DL. 2013 Nephrotoxicity
and other adverse events among inpatients
receiving liposomal amphotericin B or
amphotericin B lipid complex. Diagn. Microbiol.
Infect. Dis. 76, 361–367. (doi:10.1016/j.
diagmicrobio.2013.04.001)
23. Jaimes-Aguirre L, Gibbens-Bandala BV, Morales-
Avila E, Ocampo-García BE, Seyedeh-Fatemeh M,
Amirhosein A. 2016 Polymer-based drug
delivery systems, development and pre-clinical
status. Curr. Pharm. Des. 22, 2886–2903.
(doi:10.2174/1381612822666160217125028)
24. Carraro TCMM, Khalil NM, Mainardes RM. 2016
Amphotericin B-loaded polymeric nanoparticles:
formulation optimization by factorial design.
Pharm. Dev. Technol. 21, 140–146. (doi:10.
3109/10837450.2014.979942)
25. Jansook P, Pichayakorn W, Muankaew C,
Loftsson T. 2016 Cyclodextrin–poloxamer
aggregates as nanocarriers in eye drop
formulations: dexamethasone and amphotericin
B. Drug Dev. Ind. Pharm. 42, 1446–1454.
(doi:10.3109/03639045.2016.1141932)
26. Alvarez C, Shin DH, Kwon GS. 2016
Reformulation of fungizone by PEG-DSPE
micelles: deaggregation and detoxification of
amphotericin B. Pharm. Res. 33, 2098–2106.
(doi:10.1007/s11095-016-1948-7,).
27. Halperin A, Shadkchan Y, Pisarevsky E, Szpilman
AM, Sandovsky H, Osherov N, Benhar I. 2016
Novel water-soluble amphotericin B-PEG
conjugates with low toxicity and potent in vivo
efficacy. J. Med. Chem. 59, 1197–1206. (doi:10.
1021/acs.jmedchem.5b01862)
28. Tan TRM, Hoi KM, Zhang P, Ng SK. 2016
Characterization of a polyethylene glycol-
amphotericin B conjugate loaded with free











29. Janout V, Schell WA, Thévenin D, Yu Y, Perfect
JR, Regen SL. 2015 Taming amphotericin B.
Bioconjug. Chem. 26, 2021–2024. (doi:10.1021/
acs.bioconjchem.5b00463)
30. Ickowicz DE, Farber S, Sionov E, Kagan S,
Hoffman A, Polacheck I, Domb AJ. 2014 Activity,
reduced toxicity, and scale-up synthesis of
amphotericin B-conjugated polysaccharide.
Biomacromolecules 15, 2079–2089. (doi:10.
1021/bm5002125)
31. Ehrenfreund-Kleinman T, Azzam T, Falk R,
Polacheck I, Golenser J, Domb AJ. 2002
Synthesis and characterization of novel water
soluble amphotericin B–arabinogalactan
conjugates. Biomaterials 23, 1327–1335.
(doi:10.1016/S0142-9612(01)00251-4)
32. Kothandaraman GP, Ravichandran V, Bories C,
Loiseau PM, Jayakrishnan A. 2017 Anti-fungal
and anti-leishmanial activities of pectin-
amphotericin B conjugates. J. Drug Deliv. Sci.
Technol. 39, 1–7. (doi:10.1016/j.jddst.2017.
02.010)
33. Shepherd J, Sarker P, Swindells K, Douglas I,
MacNeil S, Swanson L, Rimmer S. 2010 Binding
bacteria to highly branched poly(N-isopropyl
acrylamide) modified with vancomycin induces
the coil-to-globule transition. J. Am. Chem. Soc.
132, 1736–1737. (doi:10.1021/ja907466y)
34. Swanson L, Rimmer S, MacNeil S, Douglas I,
Swindells K, Sarker P. 2014 Förster resonance
energy transfer confirms the bacterial-induced
conformational transition in highly-branched
poly(N-isopropyl acrylamide) with vancomycin
end groups on binding to Staphylococcus
aureus. Soft Matter 10, 5824–5835. (doi:10.
1039/C4SM00056K)
35. Sarker P, Shepherd J, Swindells K, Douglas I,
MacNeil S, Swanson L, Rimmer S. 2011 Highly
branched polymers with polymyxin end groups
responsive to Pseudomonas aeruginosa.
Biomacromolecules 12, 1–5. (doi:10.1021/
bm100922j)
36. Banshoya K, Kaneo Y, Tanaka T, Yamamoto S,
Maeda H. 2019 Synthesis and evaluation of
styrene-maleic acid copolymer conjugated
amphotericin B. Int. J. Pharm. 572, 118719.
(doi:10.1016/j.ijpharm.2019.118719)
37. Bygd HC, Forsmark KD, Bratlie KM. 2015
Altering in vivo macrophage responses with
modified polymer properties. Biomaterials 56,
187–197. (doi:10.1016/j.biomaterials.2015.
03.042)
38. Fan X, Nosov M, Carroll W, Gorelov A, Elvira C,
Rochev Y. 2014 Macrophages behavior on
different NIPAm-based thermoresponsive
substrates. J. Biomed. Mater. Res. A 102,
2901–2910. (doi:10.1002/jbm.a.34940)
39. Teratanatorn P, Hoskins R, Swift T, Douglas CWI,
Shepherd J, Rimmer S. 2017 Binding of bacteria
to poly(N-isopropylacrylamide) modified with
vancomycin: comparison of behavior of linear
and highly branched polymers.
Biomacromolecules 18, 2887–2899. (doi:10.
1021/acs.biomac.7b00800)
40. Swift T, Hoskins R, Telford R, Plenderleith R,
Pownall D, Rimmer S. 2017 Analysis using size
exclusion chromatography of poly(N-isopropyl
acrylamide) using methanol as an eluent.
J. Chromatogr. A 1508, 16–23. (doi:10.1016/j.
chroma.2017.05.050)
41. Walev I, Bhakdi S. 1996 Possible reason for
preferential damage to renal tubular epithelial
cells evoked by amphotericin B. Antimicrob.
Agents Chemother. 40, 1116–1120. (doi:10.
1128/AAC.40.5.1116)
42. Ciapetti G, Cenni E, Pratelli L, Pizzoferrato A.
1993 In vitro evaluation of cell/biomaterial
interaction by MTT assay. Biomaterials
14, 359–364. (doi:10.1016/0142-9612(93)
90055-7)
43. Hopkins S, Carter S, Swanson L, MacNeil S,
Rimmer S. 2007 Temperature-dependent
phagocytosis of highly branched poly(N-
isopropyl acrylamide-co-1,2 propandiol-3-
methacrylate)s prepared by RAFT
polymerization. J. Mater. Chem. 17, 4022–4027.
(doi:10.1039/b708415c)
44. Adjei IM, Plumton G, Sharma B. 2016 Oxidative
stress and biomaterials: the inflammatory link.
In Oxidative stress and biomaterials
(eds T Dziubla, DA Butterfield), pp. 89–115.
Cambridge, MA: Academic Press.
45. Russell EG, Cotter TG. 2015 New insight into the
role of reactive oxygen species (ROS) in cellular
signal-transduction processes. In International
review of cell and molecular biology, vol. 319
(ed. KW Jeon), pp. 221–254. Cambridge, MA:
Academic Press.
46. Janský PRL, Kopecký J. 2003 Dynamics of
cytokine production in human peripheral blood
mononuclear cells stimulated by LPS, or
infected by Borrelia. Physiol. Res. 52,
593–598.
47. De Groote D et al. 1992 Direct stimulation of
cytokines (IL-1β, TNF-α, IL-6, IL-2, IFN-γ and
GM-CSF) in whole blood. I. Comparison with
isolated PBMC stimulation. Cytokine 4,
239–248. (doi:10.1016/1043-4666(92)
90062-V)
48. Vonk AG, Netea MG, Denecker NE, Verschueren
IC, van der Meer JW, Kullberg BJ. 1998
Modulation of the pro- and anti-inflammatory
cytokine balance by amphotericin B.
J. Antimicrob. Chemother. 42, 469–474. (doi:10.
1093/jac/42.4.469)
49. Batista-Duharte A, Lastre M, Romeu B,
Portuondo DL, Téllez-Martínez D, Manente FA,
Pérez O, Carlos IZ. 2016 Antifungal and
immunomodulatory activity of a novel cochleate
for amphotericin B delivery against Sporothrix
schenckii. Int. Immunopharmacol. 40, 277–287.
(doi:10.1016/j.intimp.2016.09.008)
50. Shepherd J, Sarker P, Rimmer S, Swanson L,
MacNeil S, Douglas I. 2011 Hyperbranched
poly(NIPAM) polymers modified with antibiotics
for the reduction of bacterial burden in
infected human tissue engineered skin.
Biomaterials 32, 258–267. (doi:10.1016/j.
biomaterials.2010.08.084)
51. Swift T, Katsikogianni M, Hoskins R,
Teratarantorn P, Douglas I, MacNeil S, Rimmer S.
2019 Highly-branched poly(N-isopropyl
acrylamide) functionalised with pendant Nile
red and chain end vancomycin for the
detection of Gram-positive bacteria. Acta
Biomater. 87, 197–206. (doi:10.1016/j.actbio.
2019.01.066)
52. Matsuoka S, Ikeuchi H, Matsumori N, Murata M.
2005 Dominant formation of a single-length
channel by amphotericin B in
dimyristoylphosphatidylcholine membrane
evidenced by 13C–31P rotational echo double
resonance. Biochemistry 44, 704–710. (doi:10.
1021/bi049001k)
53. Cohen BE. 2010 Amphotericin B membrane action:
role for two types of ion channels in eliciting cell
survival and lethal effects. J. Membr. Biol. 238,
1–20. (doi:10.1007/s00232-010-9313-y)
54. De Nobel JG, Dijkers C, Hooijberg E, Klis FM. 1989
Increased cell wall porosity in Saccharomyces
cerevisiae after treatment with dithiothreitol or
EDTA. Microbiology 135, 2077–2084. (doi:10.
1099/00221287-135-7-2077)
55. Walker L et al. 2018 The viscoelastic
properties of the fungal cell wall allow traffic
of AmBisome as intact liposome vesicles.
mBio 9, e02383-02317. (doi:10.1128/mBio.
02383-17)
56. Wilcock BC, Endo MM, Uno BE, Burke MD.
2013 C20-OH of amphotericin B plays an
important role in binding the primary
sterol of human cells but not yeast cells. J. Am.
Chem. Soc. 135, 8488–8491. (doi:10.1021/
ja403255s)
57. Morais JM, Papadimitrakopoulos F, Burgess DJ.
2010 Biomaterials/tissue interactions: possible
solutions to overcome foreign body response. AAPS
J. 12, 188–196. (doi:10.1208/s12248-010-9175-3)
58. Rogers PD, Jenkins JK, Chapman SW, Ndebele K,
Chapman BA, Cleary JD. 1998 Amphotericin B
activation of human genes encoding for
cytokines. J. Infect. Dis. 178, 1726–1733.
(doi:10.1086/314495)
59. Deshpande P, Notara M, Bullett N, Daniels JT,
Haddow DB, MacNeil S. 2009 Development of a
surface-modified contact lens for the transfer
of cultured limbal epithelial cells to the cornea
for ocular surface diseases. Tissue Eng.
Part A 15, 2889–2902. (doi:10.1089/ten.tea.
2008.0528)
royalsocietypublishing.org/journal/rsos
R.
Soc.
Open
Sci.
8:
201655
15
